← Back to headlines
AEON Biopharma Reports GAAP EPS of -$0.29
AEON Biopharma announced its latest financial results, reporting a GAAP Earnings Per Share (EPS) of -$0.29.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
FDA Approves Groundbreaking New Treatment for Pancreatic Cancer
45m ago
Nutritionists Explain How Dietary Fiber Can Improve Sleep Quality
52m ago
Busy Philipps Reveals Rare Brain Tumor Diagnosis and Two Surgeries
1h ago
Closing Arguments Approach in Murder Trial of Mother Accused of Killing Three Children
1h ago